Sotrastaurin is a highly selective and potent (IC50s for PKC isotypes: alpha = 2.1 nM, ß1 = 2.0 nM, delta = 1.3 nM, epsilon = 6.2 nM, eta = 6.1 nM, T = 1.0 nM) pan-PKC inhibitor.1 Potent immunomodulatory agent that inhibits early T-cell activation and displays potential for the prevention of transplant rejection and the treatment of inflammatory diseases.2,3 Sotrastaurin has anticancer activity in various cancer models including breast4, CLL5, ocular melanoma6, and B-cell lymphoma7.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
